183 related articles for article (PubMed ID: 38018963)
1. Pharmacological validation of dihydrofolate reductase as a drug target in
Aragaw WW; Negatu DA; Bungard CJ; Dartois VA; Marrouni AE; Nickbarg EB; Olsen DB; Warrass R; Dick T
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0071723. PubMed ID: 38018963
[TBL] [Abstract][Full Text] [Related]
2. Potency boost of a
Aragaw WW; Lee BM; Yang X; Zimmerman MD; Gengenbacher M; Dartois V; Chui WK; Jackson CJ; Dick T
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34161270
[TBL] [Abstract][Full Text] [Related]
3. Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.
Gupta R; Rodrigues Felix C; Akerman MP; Akerman KJ; Slabber CA; Wang W; Adams J; Shaw LN; Tse-Dinh YC; Munro OQ; Rohde KH
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483110
[No Abstract] [Full Text] [Related]
4. Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase.
Gerum AB; Ulmer JE; Jacobus DP; Jensen NP; Sherman DR; Sibley CH
Antimicrob Agents Chemother; 2002 Nov; 46(11):3362-9. PubMed ID: 12384337
[TBL] [Abstract][Full Text] [Related]
5. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
Rosowsky A; Forsch RA; Queener SF
J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
[TBL] [Abstract][Full Text] [Related]
7. Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.
Negatu DA; Beuchel A; Madani A; Alvarez N; Chen C; Aragaw WW; Zimmerman MD; Laleu B; Gengenbacher M; Dartois V; Imming P; Dick T
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0067621. PubMed ID: 34001512
[TBL] [Abstract][Full Text] [Related]
8.
Mann L; Ganapathy US; Abdelaziz R; Lang M; Zimmerman MD; Dartois V; Dick T; Richter A
Microbiol Spectr; 2022 Dec; 10(6):e0276022. PubMed ID: 36377951
[TBL] [Abstract][Full Text] [Related]
9. Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase.
Talawanich Y; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
Acta Trop; 2015 Sep; 149():64-9. PubMed ID: 25997881
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Resistance to Folate Pathway Inhibitors in
Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
[TBL] [Abstract][Full Text] [Related]
11. Using a Fragment-Based Approach to Identify Alternative Chemical Scaffolds Targeting Dihydrofolate Reductase from
Ribeiro JA; Hammer A; Libreros-Zúñiga GA; Chavez-Pacheco SM; Tyrakis P; de Oliveira GS; Kirkman T; El Bakali J; Rocco SA; Sforça ML; Parise-Filho R; Coyne AG; Blundell TL; Abell C; Dias MVB
ACS Infect Dis; 2020 Aug; 6(8):2192-2201. PubMed ID: 32603583
[TBL] [Abstract][Full Text] [Related]
12. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
[TBL] [Abstract][Full Text] [Related]
13. The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling.
Hong W; Wang Y; Chang Z; Yang Y; Pu J; Sun T; Kaur S; Sacchettini JC; Jung H; Lin Wong W; Fah Yap L; Fong Ngeow Y; Paterson IC; Wang H
Sci Rep; 2015 Oct; 5():15328. PubMed ID: 26471125
[TBL] [Abstract][Full Text] [Related]
14. Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae.
Brophy VH; Vasquez J; Nelson RG; Forney JR; Rosowsky A; Sibley CH
Antimicrob Agents Chemother; 2000 Apr; 44(4):1019-28. PubMed ID: 10722506
[TBL] [Abstract][Full Text] [Related]
15. Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance.
Abdizadeh H; Tamer YT; Acar O; Toprak E; Atilgan AR; Atilgan C
Phys Chem Chem Phys; 2017 May; 19(18):11416-11428. PubMed ID: 28422217
[TBL] [Abstract][Full Text] [Related]
16.
Aragaw WW; Cotroneo N; Stokes S; Pucci M; Critchley I; Gengenbacher M; Dick T
Microbiol Spectr; 2022 Feb; 10(1):e0132121. PubMed ID: 35019671
[TBL] [Abstract][Full Text] [Related]
17. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.
Nahimana A; Rabodonirina M; Bille J; Francioli P; Hauser PM
Antimicrob Agents Chemother; 2004 Nov; 48(11):4301-5. PubMed ID: 15504856
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
19. Lausannevirus Encodes a Functional Dihydrofolate Reductase Susceptible to Proguanil.
Mueller L; Hauser PM; Gauye F; Greub G
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137801
[TBL] [Abstract][Full Text] [Related]
20. The discovery of 1, 3-diamino-7H-pyrrol[3, 2-f]quinazoline compounds as potent antimicrobial antifolates.
Li Y; Ouyang Y; Wu H; Wang P; Huang Y; Li X; Chen H; Sun Y; Hu X; Wang X; Li G; Lu Y; Li C; Lu X; Pang J; Nie T; Sang X; Dong L; Dong W; Jiang J; Paterson IC; Yang X; Hong W; Wang H; You X
Eur J Med Chem; 2022 Jan; 228():113979. PubMed ID: 34802838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
